BACKGROUND: Congenital hyperinsulinism (CHI) is associated with focal hyperplasia of endocrine tissue in 40-65% of patients. Focal CHI is sporadic and is caused by a germline, paternally inherited, mutation of the SUR1 (ABCC8) or KIR6.2 (KCNJ11) genes (encoding subunits of the pancreatic ATP-dependent potassium channel) together with somatic maternal haploinsufficiency for 11p15.5. Plurifocal or large forms of focal CHI are a cause of apparent failure of surgery, and their underlying mechanism has not been thoroughly investigated. PATIENTS: We here report two patients with bifocal CHI as evidenced by relapsing hypoglycemia after removal of the first focal lesion and the detection of a second, distinct, focal adenomatous hyperplasia during later surgery (patients 1 and 2) and a patient with a giant focal lesion involving the major part of the pancreas (patient 3). RESULTS: In the three patients, a germline, paternally inherited, mutation of SUR1 was found. In patients 1 and 2, haploinsufficiency for the maternal 11p15.5 region resulted from a somatic deletion specific for each of the focal lesions, as shown by the diversity of deletion break points. In patient 3, an identical somatic maternal 11p15 deletion demonstrated by similar break points was shown in two independent lesion samples, suggesting a very early event during pancreas embryogenesis. CONCLUSION: Individual patients with focal hyperinsulinism may have more than one focal pancreatic lesion due to separate somatic maternal deletion of the 11p15 region. These patients and those with solitary focal lesions may follow the two-hit model described by Knudson. The stage of embryogenesis at which the somatic event occurs may account for the observed histological diversity (early event giant lesion, later event small lesion).
BACKGROUND:Congenital hyperinsulinism (CHI) is associated with focal hyperplasia of endocrine tissue in 40-65% of patients. Focal CHI is sporadic and is caused by a germline, paternally inherited, mutation of the SUR1 (ABCC8) or KIR6.2 (KCNJ11) genes (encoding subunits of the pancreatic ATP-dependent potassium channel) together with somatic maternal haploinsufficiency for 11p15.5. Plurifocal or large forms of focal CHI are a cause of apparent failure of surgery, and their underlying mechanism has not been thoroughly investigated. PATIENTS: We here report two patients with bifocal CHI as evidenced by relapsing hypoglycemia after removal of the first focal lesion and the detection of a second, distinct, focal adenomatous hyperplasia during later surgery (patients 1 and 2) and a patient with a giant focal lesion involving the major part of the pancreas (patient 3). RESULTS: In the three patients, a germline, paternally inherited, mutation of SUR1 was found. In patients 1 and 2, haploinsufficiency for the maternal 11p15.5 region resulted from a somatic deletion specific for each of the focal lesions, as shown by the diversity of deletion break points. In patient 3, an identical somatic maternal 11p15 deletion demonstrated by similar break points was shown in two independent lesion samples, suggesting a very early event during pancreas embryogenesis. CONCLUSION: Individual patients with focal hyperinsulinism may have more than one focal pancreatic lesion due to separate somatic maternal deletion of the 11p15 region. These patients and those with solitary focal lesions may follow the two-hit model described by Knudson. The stage of embryogenesis at which the somatic event occurs may account for the observed histological diversity (early event giant lesion, later event small lesion).
Authors: Dunia Ismail; Ritika R Kapoor; Virpi V Smith; Michael Ashworth; Oliver Blankenstein; Agostino Pierro; Sarah E Flanagan; Sian Ellard; Khalid Hussain Journal: J Clin Endocrinol Metab Date: 2011-10-26 Impact factor: 5.958
Authors: Dunia Ismail; Virpi V Smith; Pascale de Lonlay; Maria-Joao Ribeiro; Jacques Rahier; Oliver Blankenstein; Sarah E Flanagan; Christine Bellanné-Chantelot; Virginie Verkarre; Yves Aigrain; Agostino Pierro; Sian Ellard; Khalid Hussain Journal: J Clin Endocrinol Metab Date: 2010-10-13 Impact factor: 5.958
Authors: Hendrik Vossschulte; Konrad Mohnike; Klaus Mohnike; Katharina Warncke; Ayse Akcay; Martin Zenker; Ilse Wieland; Ina Schanze; Julia Hoefele; Christine Förster; Winfried Barthlen; Kim Stahlberg; Susann Empting Journal: J Endocr Soc Date: 2022-04-06
Authors: Ross J Craigie; Maria Salomon-Estebanez; Daphne Yau; Bing Han; Walaa Mal; Melanie Newbould; Edmund Cheesman; Stefania Bitetti; Zainab Mohamed; Rakesh Sajjan; Raja Padidela; Mars Skae; Sarah Flanagan; Sian Ellard; Karen E Cosgrove; Indraneel Banerjee; Mark J Dunne Journal: Front Endocrinol (Lausanne) Date: 2018-10-17 Impact factor: 5.555
Authors: Elizabeth Rosenfeld; Lauren Mitteer; Kara Boodhansingh; Susan A Becker; Heather McKnight; Linda Boyajian; Amanda M Ackermann; Jennifer M Kalish; Tricia R Bhatti; Lisa J States; N Scott Adzick; Katherine Lord; Diva D De León Journal: Front Pediatr Date: 2021-07-16 Impact factor: 3.418